• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bullish Tuesday For Marijuana Stocks - Nine Energy Service, ReneSola Among Top Gainers

    3/8/22 4:46:23 PM ET
    $ACB
    $ARNA
    $CARA
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACB alert in real time by email

    GAINERS:

    • Nine Energy Service (NYSE:NINE) shares closed up 57.66% at $5.66
    • ReneSola (NYSE:SOL) shares closed up 36.36% at $8.10
    • GrowGeneration (NASDAQ:GRWG) shares closed up 11.07% at $8.53
    • Cara Therapeutics (NASDAQ:CARA) shares closed up 11.00% at $11.71
    • MedMen Enterprises (OTC:MMNFF) shares closed up 10.36% at $0.12
    • Item 9 Labs (OTC:INLB) shares closed up 8.42% at $1.03
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 7.06% at $0.34
    • Cansortium (OTC:CNTMF) shares closed up 6.36% at $0.50
    • Arena Pharmaceuticals (NASDAQ:ARNA) shares closed up 5.36% at $98.64
    • Village Farms Intl (NASDAQ:VFF) shares closed up 5.25% at $4.41
    • Charlottes Web Holdings (OTC:CWBHF) shares closed up 4.57% at $1.03
    • cbdMD (AMEX:YCBD) shares closed up 4.54% at $0.79
    • RIV Capital (OTC:CNPOF) shares closed up 4.35% at $1.08
    • Aurora Cannabis (NASDAQ:ACB) shares closed up 4.13% at $3.28
    • Curaleaf Holdings (OTC:CURLF) shares closed up 4.12% at $5.78
    • 22nd Century Group (NASDAQ:XXII) shares closed up 3.83% at $2.17
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 3.82% at $1.36
    • SOL Global Investments (OTC:SOLCF) shares closed up 3.69% at $1.19
    • MGC Pharmaceuticals (OTC:MGCLF) shares closed up 3.66% at $0.02
    • Canopy Gwth (NASDAQ:CGC) shares closed up 3.64% at $6.27
    • Tilray Brands (NASDAQ:TLRY) shares closed up 3.52% at $5.30
    • HEXO (NASDAQ:HEXO) shares closed up 3.51% at $0.57

    LOSERS:

    • Mexco Energy (AMEX:MXC) shares closed down 16.35% at $25.40
    • Neptune Wellness Solns (NASDAQ:NEPT) shares closed down 8.42% at $0.31
    • Scotts Miracle Gro (NYSE:SMG) shares closed down 5.98% at $119.23
    • Green Organic Dutchman (OTC:TGODF) shares closed down 5.31% at $0.08
    • Meridian Bioscience (NASDAQ:VIVO) shares closed down 3.72% at $24.62
    • Empower Clinics (OTC:EPWCF) shares closed down 3.22% at $0.20
    • Auxly Cannabis Group (OTC:CBWTF) shares closed down 3.16% at $0.12

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $ARNA
    $CARA
    $CGC

    CompanyDatePrice TargetRatingAnalyst
    Tilray Brands Inc.
    $TLRY
    4/3/2026$10.00Neutral → Buy
    Roth Capital
    Tilray Brands Inc.
    $TLRY
    4/2/2026$10.00Neutral → Buy
    Roth Capital
    Canopy Growth Corporation
    $CGC
    3/27/2026Buy
    Canaccord Genuity
    Scotts Miracle-Gro Company
    $SMG
    3/26/2026$67.00Overweight → Neutral
    Analyst
    Tilray Brands Inc.
    $TLRY
    1/27/2026Hold
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    More analyst ratings

    $ACB
    $ARNA
    $CARA
    $CGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: SEC Form 4 filed by Johnson Stephen L

    4/A - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    4/3/26 2:08:57 PM ET
    $SMG
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Sandoval Brian E

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    4/3/26 1:56:08 PM ET
    $SMG
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Johnson Stephen L

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    4/3/26 1:50:32 PM ET
    $SMG
    Agricultural Chemicals
    Industrials

    $ACB
    $ARNA
    $CARA
    $CGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO & CAO Scheiwer Mark J bought $49,504 worth of shares (693 units at $71.44), increasing direct ownership by 5% to 15,370 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/25/26 11:29:13 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Mongeau Luc bought $49,994 worth of shares (27,469 units at $1.82), increasing direct ownership by 3% to 812,368 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    9/23/25 4:15:11 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $ACB
    $ARNA
    $CARA
    $CGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Village Farms Announces Succession Plan for Chief Financial Officer

    Stephen Ruffini will transition from CFO after 17 years of service to assume responsibility for M&A activities Mr. Ruffini will remain CFO until a permanent replacement is identified; Company will commence formal search process LAKE MARY, Fla. and VANCOUVER, British Columbia, April 03, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF) today announced that it has begun a succession planning process for its Chief Financial Officer Stephen ("Steve") Ruffini. Mr. Ruffini will remain as CFO of the Company until a permanent replacement has been identified.   Mr. Ruffini will remain an employee of the Company, not only to help ens

    4/3/26 7:00:00 AM ET
    $VFF

    ScottsMiracle-Gro Reaffirms Fiscal 2026 Guidance; Margin Recovery and Growth Plans Remain on Track

    MARYSVILLE, Ohio, April 02, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE:SMG), the leading marketer of branded consumer lawn and garden products in North America, announced that it is reaffirming its fiscal 2026 guidance as it does not expect the significant global commodity impacts from the Iran War to affect its full-year outlook. The Company noted that approximately 80 percent of its commodities for the fiscal year were locked by the close of its second quarter on March 28, 2026. Additionally, around 90 percent of its cost of goods sold are sourced domestically, including nearly 100 percent of the urea that is a primary input in its fertilizer products. The Company obt

    4/2/26 7:00:00 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare

    Company brings one of the only combined clinical and toxicological safety dataset in the hemp-derived CBD category into a new provider channel as CMS activates cannabinoid access within value-based care modelsCHARLOTTE, N.C., April 1, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leader in science-driven cannabinoid products, today announced the launch of its clinical healthcare channel, positioning the Company to support physicians, health systems, and value-based care organizations as federal policy establishes structured pathways for hemp-derived cannabinoid products within Medicare programs.

    4/1/26 8:30:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $ACB
    $ARNA
    $CARA
    $CGC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    December 10, 2021 - Coronavirus (COVID-19) Update: December 10, 2021

    For Immediate Release: December 10, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On December 9, 2021, the FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information. The update added new information about the Meridian Bioscience, Inc. Revogene SARS-CoV-2 test, inc

    12/10/21 1:56:40 PM ET
    $VIVO
    Power Generation
    Utilities

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $ARNA
    $CARA
    $CGC
    SEC Filings

    View All

    Village Farms International Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Village Farms International, Inc. (0001584549) (Filer)

    4/3/26 7:30:09 AM ET
    $VFF

    SEC Form DEFA14A filed by Corbus Pharmaceuticals Holdings Inc.

    DEFA14A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    4/2/26 4:49:55 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Corbus Pharmaceuticals Holdings Inc.

    DEF 14A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    4/2/26 4:47:09 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $ARNA
    $CARA
    $CGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/3/26 10:44:58 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/2/26 7:55:13 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Canopy Growth

    Canaccord Genuity initiated coverage of Canopy Growth with a rating of Buy

    3/27/26 8:46:41 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $ARNA
    $CARA
    $CGC
    Leadership Updates

    Live Leadership Updates

    View All

    Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the "Transaction") of Sanity Group GmbH ("Sanity Group") and the related private placement financing (the "Private Placement") with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco ("BAT") at the Company's annual general and special meeting of shareholders (the "Shareholders") held on March 30, 2026 (the "Meeting"). Shareholders approved an ordinary resolution (the "Transaction Resolution") authorizing (i)

    3/30/26 8:30:00 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canopy Growth Announces Storz & Bickel Executive Transition

    David Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into a global premium vaporization technology leader, passes the torch following 25 years of transformational leadership Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization technology. Today, it sets the standard for innovation, p

    3/27/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

    ISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Recommending Shareholders Vote FOR the Transaction Resolution Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has recommended that holders of common shares of Organigram ("Shareholders") vote FOR the ordinary resolution (the "Transaction Resolution") to approve the indirect acquisition of Sanity Group GmbH ("Sanity") at the Company's Annual General and Special Meeting of Shareholders (the "Mee

    3/23/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $ARNA
    $CARA
    $CGC
    Financials

    Live finance-specific insights

    View All

    22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results

    VLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci

    3/26/26 6:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

    NEW YORK and LEAMINGTON, Ontario, March 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the third fiscal quarter which ended February 28, 2026, before the financial markets open on Wednesday, April 1, 2026. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Ti

    3/25/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    GrowGeneration Reports Fourth Quarter and Full Year 2025 Financial Results

    Full Year Net Sales of $161.7 million including Proprietary Brand Sales of $44.0 million Full Year Proprietary Brand Penetration Increased to 32.8% up from 24.2% in the prior year Full Year GAAP Net Loss Improved by $25.5 million; Adjusted EBITDA Improved by $8.5 million $46.1 million of Cash and Marketable Securities and no debt Board Authorizes $10 Million Share Repurchase Program 2026 Outlook: Revenue of $162 million to $168 million and Breakeven Adjusted EBITDA(1) DENVER, March 19, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG), ("GrowGeneration," "GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled envir

    3/19/26 4:05:00 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $ACB
    $ARNA
    $CARA
    $CGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care